Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
J Hosp Infect ; 146: 31-36, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38286238

RESUMO

BACKGROUND: Candida auris is an emerging multidrug-resistant yeast which can cause severe infection in hospitalized patients. Since its first detection in 2009, C. auris has spread globally. The control and elimination of this pathogen in a hospital setting is particularly challenging because of its ability to form biofilms, allowing for long-term patient colonization and persistence in the environment. Identification of C. auris from cultures is difficult due to the morphologic similarities to other yeasts, its slow growth, and the low culture sensitivity when using standard agars and temperatures. AIM: We have developed a screening protocol for C. auris colonization using an in-house-developed polymerase chain reaction (PCR), combined with confirmatory culture in optimized conditions. METHODS: C. auris-specific primers and probe were developed, targeting the internal transcribed spacer (ITS) region, and specificity was confirmed in silico using the BLAST tool. The PCR was validated using a panel of 12 C. auris isolates and 103 isolates from 22 other Candida species and was shown to be 100% accurate. The limit of detection of the assay was determined at approximately four cells per PCR. FINDINGS: C. auris screening was introduced on February 15th, 2023, and was used for patients who had been admitted to a healthcare facility abroad in the two months prior to admission to our hospital. The screening protocol included swabs from nose, throat, rectum, axilla, and groin. In the first eight months, 199 patients were screened and seven were found positive (4%). CONCLUSION: Our proposed screening protocol may contribute to control C. auris in hospitals.


Assuntos
Candidíase , Humanos , Candidíase/diagnóstico , Candida auris , Candida/genética , Leveduras , Antifúngicos , Testes de Sensibilidade Microbiana
3.
Epidemiol Infect ; 145(12): 2520-2529, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28521845

RESUMO

Introduction of antiretroviral therapy (ART) has dramatically reduced the incidence of infectious ocular diseases in human immunodeficiency virus (HIV)-infected individuals. However, the effects of long-term ART and chronic HIV infection on the eye are ill-defined. This study determined the occurrence and severity of ocular diseases among 342 participants in a rural South African setting: HIV-naïve (n = 105), HIV-infected ART-naïve (n = 16), HIV-infected on ART for 36 months (long-term ART; n = 165). More HIV-infected participants presented with an external eye condition, in particular blepharitis, than HIV-naïve individuals (18% vs. 7%; age-adjusted odds ratio (aOR) = 2·8, P < 0·05). Anterior segment conditions (particularly keratoconjunctivitis sicca and pterygium) were also more common (50% vs. 27%; aOR = 2·4; P < 0·01). Compared with individuals on short-term ART, participants receiving long-term ART were more likely to have clinically detectable cataract (57% vs. 38%; aOR = 2·2, P = 0·01) and posterior segment diseases, especially HIV retinopathy (30% vs. 11%; aOR = 3·4, P < 0·05). Finally, long-term ART was significantly associated with presence of HIV retinopathy (P < 0·01). These data implicate that ocular disease is more common and of more diverse etiology among HIV-infected individuals, especially those on long-term ART and suggest that regular ophthalmological monitoring of HIV-infected individuals on ART is warranted.


Assuntos
Antirretrovirais/administração & dosagem , Oftalmopatias/epidemiologia , Infecções por HIV/tratamento farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Fatores de Risco , População Rural , África do Sul/epidemiologia , Adulto Jovem
4.
Eur J Clin Microbiol Infect Dis ; 35(9): 1403-9, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27236644

RESUMO

The purpose of this investigation was to determine the clinical and corneal microbial profile of infectious keratitis in a high human immunodeficiency virus (HIV) prevalence setting in rural South Africa. Data in this cross-sectional study were collected from patients presenting with symptoms of infectious keratitis (n = 46) at the ophthalmology outpatient department of three hospitals in rural South Africa. Corneal swabs were tested for herpes simplex virus type 1 (HSV-1) and 2 (HSV-2), varicella zoster virus (VZV) and adenovirus DNA by real-time polymerase chain reaction (PCR) and for bacteria and fungi by culture. Based on clinical history, disease characteristics and laboratory results, 29 (63 %) patients were diagnosed as viral keratitis, including 14 (48 %) viral keratitis cases complicated by bacterial superinfection, and 17 (37 %) as bacterial keratitis. VZV and HSV-1 DNA was detected in 11 (24 %) and 5 (11 %) corneal swabs, respectively. Among clinically defined viral keratitis cases, a negative viral swab was predominantly (93 %) observed in cases with subepithelial inflammation and was significantly associated with an increased duration of symptoms (p = 0.003). The majority of bacteria cultured were Gram-positive (24/35), including Staphylococcus epidermidis and S. aureus. Viral aetiology was significantly associated with a history of herpes zoster ophthalmicus (p < 0.001) and a trend was observed between viral aetiology and HIV infection (p = 0.06). Twenty-one (47 %) keratitis cases were complicated by anterior uveitis, of which 18 (86 %) were HIV-infected cases with viral keratitis. The data implicate a high prevalence of herpetic keratitis, in part complicated by bacterial superinfection and/or uveitis, in HIV-infected individuals presenting with infectious keratitis in rural South Africa.


Assuntos
Bactérias/isolamento & purificação , Córnea/microbiologia , Córnea/virologia , Fungos/isolamento & purificação , Ceratoconjuntivite Infecciosa/microbiologia , Ceratoconjuntivite Infecciosa/virologia , Vírus/isolamento & purificação , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Bactérias/classificação , Técnicas Bacteriológicas , Estudos Transversais , DNA Viral/genética , DNA Viral/isolamento & purificação , Feminino , Fungos/classificação , Infecções por HIV/complicações , Infecções por HIV/epidemiologia , Humanos , Ceratoconjuntivite Infecciosa/epidemiologia , Masculino , Pessoa de Meia-Idade , Prevalência , População Rural , África do Sul/epidemiologia , Vírus/classificação , Adulto Jovem
5.
East Afr Med J ; 86(6): 254-8, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20358786

RESUMO

OBJECTIVE: To describe the presentation and management of maxillofacial trauma. DESIGN: A retrospective study. SETTING: Department of Oral and Maxillofacial Surgery, Muhimbili National Hospital (MNH), Dar es Salaam, Tanzania. SUBJECTS: Patients presenting with maxillofacial trauma at the oral and maxillofacial surgery department of the MNH over a six year period (2001-2007). METHOD: Information was gathered including age, gender, length of interval between injury and presentation to the hospital, aetiology, pattern of soft tissue injury and fractures, therapy, co-morbidity, complications and number of hospitalisation days. RESULTS: The 21-30-year old age group was most affected. The overall male to female ratio was 4.3:1. The major cause of maxillofacial trauma was road traffic accidents (42.3%), followed by assaults (39.1%). Over 90% of the patients sustained soft tissue injuries, with cut wounds seen most frequently (45.0%). Of the soft tissue injuries, 75% required surgical intervention. Most of the fractures were located in the mandible (52.8%). Accompanying injuries elsewhere in the body occurred in 51.5%. Complications occurred in 13.3% of the cases. The mean hospitalisation period was 4.3 days. CONCLUSION: Road traffic accidents and assaults were the most common causes of maxillofacial trauma. Males below forty years of age were the majority of the victims.


Assuntos
Traumatismos Maxilofaciais , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Traumatismos Maxilofaciais/etiologia , Traumatismos Maxilofaciais/patologia , Traumatismos Maxilofaciais/terapia , Pessoa de Meia-Idade , Tanzânia , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...